There is clinical and preclinical evidence for low levels of D2 dopamine receptors in patients with obesity where there is radiologic evidence (PET) of less availability of D2 dopamine receptors in the same areas. The gene discussed is DRD2; the disease is obesity due to melanocortin 4 receptor deficiency.